ATCT-27NRG ONCOLOGY/RTOG 0929: A RANDOMIZED PHASE I/II STUDY OF ABT-888IN COMBINATION WITH TEMOZOLOMIDE IN RECURRENT TEMOZOLOMIDE RESISTANT GLIOBLASTOMA Article

Robins, H Ian, Zhang, Peixin, Gilbert, Mark et al. (2015). ATCT-27NRG ONCOLOGY/RTOG 0929: A RANDOMIZED PHASE I/II STUDY OF ABT-888IN COMBINATION WITH TEMOZOLOMIDE IN RECURRENT TEMOZOLOMIDE RESISTANT GLIOBLASTOMA . NEURO-ONCOLOGY, 17(suppl_5), v7-v7. 10.1093/neuonc/nov206.27

cited authors

  • Robins, H Ian; Zhang, Peixin; Gilbert, Mark; Chakravarti, Arnab; deGroot, John; Grimm, Sean; Wang, Fen; Lieberman, Frank; Krauze, Andra; Sharma, Anand; Mohile, Nimish; Kee, Andrew; Colman, Howard; Cavaliere, Robert; Kesari, Santosh; Chmura, Steven; Mehta, Minesh

authors

publication date

  • November 1, 2015

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Orphan Drug
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • v7

end page

  • v7

volume

  • 17

issue

  • suppl_5